Dietary β-1,3/1,6-Glucan from Baker's Yeast Supports Upper Respiratory Mucosal Immune Health in Healthy Adults: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial.
Trial report in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Takashi KannoLaboratory for Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Sciences, Hachioji 192-0392, Japan.
Ken-Ichi IshibashiLaboratory of Host Defense and Responses, Faculty of Nutrition, Kagawa Nutrition University, Sakado 350-0288, Japan.
Shota KajiyamaR&D Headquarters, Life Science Research Department, Kobayashi Pharmaceutical Co., Ltd., Ibaraki 567-0057, Japan.
Takanori IkawaR&D Headquarters, Life Science Research Department, Kobayashi Pharmaceutical Co., Ltd., Ibaraki 567-0057, Japan.
Taiki MoritaR&D Headquarters, Life Science Research Department, Kobayashi Pharmaceutical Co., Ltd., Ibaraki 567-0057, Japan.
Kenta MurataR&D Headquarters, Life Science Research Department, Kobayashi Pharmaceutical Co., Ltd., Ibaraki 567-0057, Japan.ORCID 0000-0002-6751-049X
Shuu ImaiR&D Headquarters, Life Science Research Department, Kobayashi Pharmaceutical Co., Ltd., Ibaraki 567-0057, Japan.
Machiko NishiokaR&D Headquarters, Life Science Research Department, Kobayashi Pharmaceutical Co., Ltd., Ibaraki 567-0057, Japan.
Yoshiyuki AdachiLaboratory for Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Sciences, Hachioji 192-0392, Japan.ORCID 0000-0001-7164-6237
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Dietary β-1,3/1,6-Glucan from Baker's Yeast Supports Upper Respiratory Mucosal Immune Health in Healthy Adults: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial. · full record | Socratic